References
- Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. NatMed1996; 2: 1104–1108.
- Chulanov VP, Shipulin GA, Schafer S, Gerlich WH. Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. JMed Wro/2003; 69:313–323.
- Roth WK, Weber M, Peterson D, eta]. NAT for HBV and anti-HBc testing increase blood safety. Transksion2002; 42: 869–875.
- Meisel H, Endres A, Walther HU, Wend UC, Gerlich WH. Transmission of hepatitis B virus two months prior to HBsAg positivity of donor blood. Transfus Med Hemother2003; 30:228–231.
- Soldan K, Barbara JA, Dow BC. Transfusion-transmitted hepatitis Bvirus infection in the UK: a small and moving target. ToxSang2002; 83: 305–308.
- Minegishi K, Yoshikawa A, Kishimoto S, et al, and the Japanese Red Cross NAT Screening Research Group. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening. ToxSang2003; 84: 287–291.
- Kleinman SH, Kuhns MC, Todd DS, et al, and the Retrovirus Epidemiology Donor Study. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43:696–704.
- Grob P. Jilg W, Bornhak H, eta]. The serological pattern "anti HBc alone". Report on a workshop. JMed Wro/2000; 62:450–455.
- Awerkiew S, Daumer M, Reiser M, et al. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. JClin Wro/2007; 98: 83–86.
- Gartner BC, Jung W, Welsch C, eta]. Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient under allogeneic stem cell transplantation. J Clin Wrol 2007; 38: 146–148.
- Hadler SC, Francis DP, Maynard JE, eta]. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. NEngl JMed 1986; 315: 209–214.
- Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. Large surface proteins of hepatitis B virus containing the pre-S sequence. J Wrol 1984; 52:396–402.
- Neurath AR, Kent SB, Strick N, Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1986; 46:429–436.
- Glebe D, Aliakbari M, Krass P, Knoop E, Valerius KP, Gerlich WH. PreS1 antigen dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Wro/2003; 77:9511–9521.
- Glebe D, Urban S, Knoop EV, eta]. Mapping of the hepatitis B virus attachment site by infection-inhibiting preS1 lipopeptides using Tupaia hepatocytes. Gastroentero12005; 129:234–245.
- Westhoff TH, Jochimsen F, Schmittel A, eta]. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 2003; 102: 1930.